Genedrive Share Discussion Threads

[andymunchkin] 09/2/2021 17:21

heGang isHere

[andymunchkin] 09/2/2021 17:20

oilisgold7 Feb '21 - 20:18 - 4180 of 4466
0 1 2
How many punters were deceived by the ceo?. How can you forget?. RNS was not issued at 7am, knowibg well the share was spiking to 300p. A lot of investors were 60% down in an instant abd many still down. Instead of making money in covid stocks, LAMBS got fleeced. I can never trust this CEO.
oilisgold7 Feb '21 - 20:19 - 4181 of 4466
0 1 2
Be very very carefull here.

[andymunchkin] 09/2/2021 17:17

tisBeing pumpdOn mulltipleThreads byBunzr cnt massivDump isOD

[blackvulture] 09/2/2021 16:43

South Africa's decision to halt its rollout of the Oxford-AstraZeneca vaccine after a study showed "disappointing" results against its new Covid-19 variant may have left the nation in shock, but it also shows how scientists are at the forefront of the battle against coronavirus.Going to need a few more tests.

[hooded claw] 09/2/2021 16:38

Actybod, OK fair enough. My calcs say hold on to them like your are superglued to them :)

[bunz3] 09/2/2021 16:11

milliecusto .the will take entire shareholding ,they needing shares ,thinking

another nice move up Tomorrow looks being seen as they look to be running so low with share supply

[janhar] 09/2/2021 16:09

I have him on filter - cuts out the drivel

[bunz3] 09/2/2021 16:01

look at the size of delayed trades ,

can see why N T to buy as mms look to be running low with share supply to fill these orders

[bunz3] 09/2/2021 15:58

Somme one loading up with these shares here

some one looks to be building a good holding

nearly 7 million traded Today

[bunz3] 09/2/2021 15:55

some might sell if £2 by Friday.

I will not be one of the sellers at that price

[actybod] 09/2/2021 15:55

They say hold on ;-)I replied to someone about 150 and the 2 min drop who seemed to have got freaked out by it.

[bunz3] 09/2/2021 15:50

even at £10 a share personly might sell any
and share price only at £1,30 ,
seen how ncyt moved up from £2,20 to £12

with the potential here

no interest in selling at a low price

after this rns


Distribution agreement with Beckman Coulter

[hooded claw] 09/2/2021 15:47

So what do your spreadsheets say ? :)

[hooded claw] 09/2/2021 15:46

I already have worked it out that is why I am not selling at this price "even after the rise"You are the one who doesn't seem to get the scale of the BC partnership with that comment

[bunz3] 09/2/2021 15:44

so many buyers loading up as getting closer to Mid February

almost 7 million volume Today

[bunz3] 09/2/2021 15:42

strong buying as more buyers pick up share

last 20 minutes might be interesting to watch

with this current buying

[actybod] 09/2/2021 15:42

Work it out for yourself mate as I like to keep my analytical models and spreadsheets with my stress testing scenarios to myself using my Monte Carlo simulation techniques ;-)

[bunz3] 09/2/2021 15:41

now back up to 1,35 already

looking like a £1,40 finish
or maybe even higher if NT to buy stops happening

if getting quoted NT to buy if keep trying hopefully will be able get buy quote

The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.



David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations

[oilisgold] 09/2/2021 15:36

We Lambs just are Lambs, the sheep are ii and they are selling. I expect another RNS saying More selling today

[oilisgold] 09/2/2021 15:35

Sellers are big ii, not some Lambs like us

[hooded claw] 09/2/2021 15:35

Actybod, then what is the market cap if GDR run beads at 50% capacity?

[oilisgold] 09/2/2021 15:34

not a nice feeling if some have bought and now being quoted N T to sell again



especially as getting closer to mid February